Docetaxel Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
Addition of:
Acute Myeloid Leukemia
Cutaneous Reactions
Neurologic Reactions
Eye...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Acute Leukemia | Acute Myeloid Leukemia | Docetaxel | Drugs & Pharmacology | Leukemia | Neurology | Taxotere